The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 01, 2019

Filed:

Mar. 27, 2015
Applicant:

Invictus Oncology Pvt. Ltd., Delhi, IN;

Inventors:

Monideepa Roy, Delhi, IN;

Samad Hossain, Delhi, IN;

Aniruddha Sengupta, Delhi, IN;

Sanghamitra Mylavarapu, Delhi, IN;

Shiladitya Sengupta, Waltham, MA (US);

Anubhab Mukherjee, Delhi, IN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 31/282 (2006.01); A61K 31/7068 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 9/127 (2006.01); C12Q 1/68 (2018.01); G01N 33/574 (2006.01); C12Q 1/6886 (2018.01); A61K 47/54 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/337 (2013.01); A61K 9/127 (2013.01); A61K 9/1271 (2013.01); A61K 31/282 (2013.01); A61K 31/7068 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/543 (2017.08); A61K 47/545 (2017.08); A61K 47/548 (2017.08); A61K 47/554 (2017.08); C12Q 1/6886 (2013.01); G01N 33/57484 (2013.01); A61K 2039/505 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present disclosure relates generally to supramolecular combinatorial therapeutics, compositions comprising same, and uses thereof. In particular, the present disclosure provides hydrophobic taxane-lipid covalent conjugates which create supramolecular assembly, for example, within lipid bilayer, providing an extra stabilization resulting in increased intratumoral concentration and hence increased efficacy. The present disclosure also provides supramolecular combinatorial therapeutics, wherein a taxane-lipid conjugate is combined with one or more of a platinum compound, a kinase inhibitor, and an immunoregulator, each of which is optionally conjugated with a lipid.


Find Patent Forward Citations

Loading…